.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Moodys
Cantor Fitzgerald
Merck
Harvard Business School
Novartis
Colorcon
Baxter
AstraZeneca
McKinsey

Generated: November 21, 2017

DrugPatentWatch Database Preview

DOXERCALCIFEROL Drug Profile

« Back to Dashboard

What is the patent landscape for Doxercalciferol, and when can generic versions of Doxercalciferol launch?

Doxercalciferol is a drug marketed by Hikma Pharms, Rising Pharms Inc, Sandoz Inc, Akorn Inc, West-ward Pharms Int, and Amneal Pharms Co. and is included in eight NDAs.

The generic ingredient in DOXERCALCIFEROL is doxercalciferol. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the doxercalciferol profile page.

Pharmacology for DOXERCALCIFEROL

Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION091101-001Aug 30, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION203929-001May 7, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Rising Pharms Inc
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL201518-003Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION208974-001May 24, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL091433-001Sep 23, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION208975-001May 24, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Rising Pharms Inc
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL201518-001Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Rising Pharms Inc
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL201518-002Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION203929-002Mar 28, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION200926-001Feb 4, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Citi
Moodys
Daiichi Sankyo
Healthtrust
Cantor Fitzgerald
Teva
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot